335 related articles for article (PubMed ID: 33171065)
21. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
[TBL] [Abstract][Full Text] [Related]
22. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex.
Ritter DM; Fessler BK; Ebrahimi-Fakhari D; Wei J; Franz DN; Krueger DA; Trout AT; Towbin AJ
Orphanet J Rare Dis; 2022 Mar; 17(1):124. PubMed ID: 35292049
[TBL] [Abstract][Full Text] [Related]
25. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.
Cai X; Pacheco-Rodriguez G; Fan QY; Haughey M; Samsel L; El-Chemaly S; Wu HP; McCoy JP; Steagall WK; Lin JP; Darling TN; Moss J
Am J Respir Crit Care Med; 2010 Dec; 182(11):1410-8. PubMed ID: 20639436
[TBL] [Abstract][Full Text] [Related]
27. Tuberous sclerosis complex for the pulmonologist.
Rebaine Y; Nasser M; Girerd B; Leroux C; Cottin V
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348978
[TBL] [Abstract][Full Text] [Related]
28. A second hit somatic (p.R905W) and a novel germline intron-mutation of TSC2 gene is found in intestinal lymphangioleiomyomatosis: a case report with literature review.
Han B; Lee J; Kwak YJ; Kim HY; Lee KH; Shim Y; Lee H; Park SH
Diagn Pathol; 2021 Aug; 16(1):83. PubMed ID: 34465349
[TBL] [Abstract][Full Text] [Related]
29. Novel TSC1 and TSC2 gene mutations in Chinese patients with tuberous sclerosis complex.
Yu T; He Y; Li N; Zhou Y; Wang Z; Fu Q; Wang J; Wang J
Clin Neurol Neurosurg; 2017 Mar; 154():104-108. PubMed ID: 28178598
[TBL] [Abstract][Full Text] [Related]
30. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
31. A Case of Tuberous Sclerosis Complex with Lymphangioleiomyomatosis and Renal Cell Carcinoma.
Wu Y; Li H; Yu X; Lin M; Chen Y
Onco Targets Ther; 2020; 13():12421-12426. PubMed ID: 33293833
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of TSC1 and TSC2 in Japanese patients with tuberous sclerosis complex revealed higher incidence of TSC1 patients than previously reported.
Niida Y; Wakisaka A; Tsuji T; Yamada H; Kuroda M; Mitani Y; Okumura A; Yokoi A
J Hum Genet; 2013 Apr; 58(4):216-25. PubMed ID: 23389244
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
Choi JE; Chae JH; Hwang YS; Kim KJ
Brain Dev; 2006 Aug; 28(7):440-6. PubMed ID: 16554133
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).
Trindade AJ; Medvetz DA; Neuman NA; Myachina F; Yu J; Priolo C; Henske EP
PLoS One; 2013; 8(3):e60014. PubMed ID: 23555865
[TBL] [Abstract][Full Text] [Related]
35. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex.
Yang HM; Choi HJ; Hong DP; Joo SY; Lee NE; Song JY; Choi YL; Lee J; Choi D; Kim B; Park HJ; Park JB; Kim SJ
Exp Mol Pathol; 2014 Dec; 97(3):440-4. PubMed ID: 25281918
[TBL] [Abstract][Full Text] [Related]
36. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
Yu J; Astrinidis A; Henske EP
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
[TBL] [Abstract][Full Text] [Related]
38. Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis.
Suspitsin EN; Yanus GA; Dorofeeva MY; Ledashcheva TA; Nikitina NV; Buyanova GV; Saifullina EV; Sokolenko AP; Imyanitov EN
J Hum Genet; 2018 May; 63(5):597-604. PubMed ID: 29476190
[TBL] [Abstract][Full Text] [Related]
39. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
